Invested Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.06M Sell
885
-6
-0.7% -$6.13K 0.94% 27
2026
Q1
$820K Sell
891
-74
-8% -$75K 0.83% 28
2025
Q4
$1.04M Buy
965
+91
+10% +$87K 1.07% 21
2025
Q3
$688K Buy
+874
New +$650K 1% 24

Other funds holding LLY

Invested Advisors's LLY Position: Q2 2026 in Review

Invested Advisors reduced its Eli Lilly (LLY) stake by 0.67% in Q2 2026, selling an estimated $6.13K and leaving 885 shares worth $1.06M. The position accounts for 0.94% of the portfolio, ranked #27.

Invested Advisors first reported a position in LLY in Q3 2025 and has held it in 4 quarters since. 2,672 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Invested Advisors held 885 shares of Eli Lilly worth $1.06M as of Q2 2026.
  • Invested Advisors sold 6 Eli Lilly shares in Q2 2026, an estimated $6.13K.
  • Eli Lilly made up 0.94% of Invested Advisors's portfolio in Q2 2026, its #27 holding.
  • Invested Advisors first reported a position in Eli Lilly in Q3 2025 and has held it in 4 quarters since.
  • 2,672 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Invested Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.